Document is current
Any future updates will be listed below
-
Authors
Kruse, Teresa https://orcid.org/0000-0002-3431-7749
Leflerovà, Diana
Cap, Annette
Portegys, Sara
Wirth, Brunhilde
Heller, Raoul
Brakemeier, Svenja
Hagenacker, Tim
Braumann, Bert
Wunderlich, Gilbert
-
Clinical Trials BETA
Clinical trials referenced in this document:
drks00015842 at German Clinical Trials RegisterDocuments that mention this clinical trial
Oral functions in adult persons with spinal muscular atrophy compared to a healthy control group: a prospective cross-sectional study with a multimodal approach
https://doi.org/10.1186/s13023-024-03405-5
Objective measurement of oral function in adults with spinal muscular atrophy
https://doi.org/10.1186/s13023-023-02688-4
-
Funding
Funding for this research was provided by:
Biogen
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 18 July 2024
Accepted: 6 October 2024
First Online: 15 October 2024
Declarations
:
: The study was approved by the Ethics Committee of the Medical Faculty of the University of Cologne (Reference Number: 19-1137) and by the Ethics Committee of the Medical Faculty of the University of Essen (Reference Number: 21-9851-BO). Each subject provided informed consent.
: Not applicable.
: T. Kruse and S. Portegys have received honoraria from Biogen for lectures. T. Kruse received financial research support from Biogen. T. Hagenacker received advisory and lecture honoraria and research support from Biogen, Roche and Novartis. G. Wunderlich has received advisory board honoraria and speaker fees from Alnylam, Hormosan, Pfizer and Sobi outside of the submitted work. D. Leflerovà, A. Cap, B. Braumann, R. Heller and S. Brakemeier have no conflicts of interests. B. Wirth received honoraria for lectures, workshops and interviews from Biogen and AveXis / Novartis. The funder had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.
